Molecular Diagnostics Market By Product (Reagents And Kits, Instruments, Services And Software), By Technology (Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, Insitu Hybridization, Microarray), By Application (Infectious Disease, Oncology, Next Generation Sequencing, Dna Sequencing, Microbiology ) - Growth, Share, Opportunities & Competitive Analysis, 2017 - 2025
This report on global molecular diagnostics market studies various products, applications and technologies used in the field of molecular diagnostics. Increasing number of patients suffering with chronic illnesses requiring prompt diagnosis, rising demand for personalized medication, advent of pharmacogenomics and government initiatives in promoting public health and welfare will propel the molecular diagnostics market. The limiting factors related to this market is the complex regulatory scenario for approvals to molecular diagnostic kits which vary according to countries. Technological advancement in the design and manufacture of diagnostic kits will result into deep market penetration of the molecular diagnostics solutions in the market.
For the purpose of this study, the various products studied include reagents and kits, instruments, services and software; applications studied for the purpose of this research are segmented as infectious disease, oncology, next generation sequencing, DNA sequencing, microbiology and others. The molecular diagnostic technologies are further categorized as polymerase chain reaction, isothermal nucleic acid amplification technology, in situ hybridization, microarray and others. Market size estimates and forecast for these segments for the period 2015 to 2025 are provided in terms of US$ Mn along with the respective CAGRs for the period 2017 to 2025, considering 2016 as the base year.
The geographic segmentation of the global molecular diagnostics market is performed for the regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa markets. The regions are also further sub-segmented on the basis of major countries:
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- Latin America
- Mexico
- Brazil
- Rest of LATAM
- Middle East and Africa
- GCC
- Rest of Middle East and Africa
Market size estimates and forecast for these segments for the period 2015 to 2025 are provided in terms of US$ Mn along with the respective CAGRs for the period 2017 to 2025, considering 2016 as the base year.
This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global molecular diagnostics market. Competition assessment tools such as Porter’s five forces analysis, market attractiveness assessment and competitive landscape analysis by key players are also presented in the study. Furthermore, this report concludes with profiling of key players currently enjoying prominent position in the global molecular diagnostics market. The key players profiled in this report are Abbott Laboratories, Inc., Alere, Inc., Bayer AG, Becton Dickinson and Company, BioMerieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation, F.Hoffman La-Roche Ltd., Novartis AG, Qiagen N.V., Siemens Healthcare, and Sysmex Corporation.
Based on product, the global molecular diagnostics market is categorized into
- Reagents and Kits
- Instruments
- Services and Software
Diverse reagents and kits such as acetonitrile, methane, Baeyer’s reagent, carbon disulfide, Brdu ELISA kit, typhoid kit, hepatitis B detection kit etc. are available to perform clinical and molecular diagnosis of diseases. Sophisticated instruments such as high performance liquid chromatography (HPLC), mass spectrometry, gas chromatography and nuclear magnetic resonance (NMR) are employed to identify and detect various pathogens and other biopsy parameters present in the samples obtained from patients suffering with different ailment. Software that are utilized in these instruments are undergoing rapid transition in order to meet the requirement of accurate, precise and reliable data analysis and interpretation of the disease under investigation. In 2016, reagent and kits held the largest revenue share in the product segments due to its diverse application in hospitals, research organization and academic institutions and high reliability and interpretation as compared to other automated tools employed for diagnosis like sonography, CT scan and MRI. Additionally, instruments is estimated to be the fastest growing segment over the forecast period 2017-2025, majorly due to factors such as technological advancement in design and manufacture, easy handling due to enhanced automation of instruments and less time taken to perform the diagnosis as compared to the conventional techniques.
Based on application areas, the global molecular diagnostics market is categorized into
- Infectious Diseases
- Oncology
- Next Generation Sequencing
- DNA Sequencing
- Microbiology
- Others
Molecular diagnostics is utilized for identification of biological markers in the human genome in order to identify gene expression respective to diseases. It is very vital in the early diagnosis of life threatening diseases where effective treatment regimen is considered immediately. Emergence of infectious diseases such as from Ebola virus and Zika virus, where early disease etiology and symptoms are difficult to detect and interpret, drives the need for molecular diagnosis. Molecular diagnostics helps to decide treatment regimen in accordance to the nature of disease and patients.
Among the considered application areas, infectious diseases hold the largest market in the application segment for the base year 2016, chiefly due to factors such as rising prevalence of infectious diseases, increasing number of primary healthcare centers in both the developed and developing worlds, government initiatives and healthcare expenditure to fight fatal disease like malaria, cholera, tuberculosis, AIDS and HPV. Oncology will be the fastest growing market in the application segment throughout the forecast period 2017-2025, due to increasing number of patients suffering with cancer, rising public awareness leading to early disease diagnosis and treatment, evolved reimbursement scenario regarding disease diagnosis.
Based on technology, the global molecular diagnostics market is categorized into
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology
- In situ Hybridization
- Microarrays
- Others
Molecular diagnostic techniques are crucial in healthcare management as they are useful in improving patient care, contribute to protect consumer health, and assistive in limiting the healthcare expenditure, which is a major economic issue throughout the world. Rising public awareness and inclination towards healthy and hygienic lifestyle, outbreak of pandemic diseases and increasing number of primary healthcare centers and supportive regulatory approval for molecular diagnostic products and services are the factors that propel the growth of global molecular diagnostics market. In 2016, polymerase chain reaction (PCR) was observed to be the largest technology segment. Vitality of PCR technology in early detection of rare diseases, rising demand for personalized medication and pharmacogenomics, and assistance in establishing DNA sequence of patients which will be helpful in the prevention of several life threatening diseases are the key factors driving this segment. Microarray will be the fastest growing market in the technology segment throughout the forecast period 2017-2025, majorly due to its ability to detect different types of cancer on the basis of the patterns of gene activity in the tumor cells; increasing demand for toxicogenomics in determining antibiotics treatment due to rising prevalence of drug resistant bacterial infection. Overall, the global molecular diagnostics market is highly competitive with presence of multiple players like F.Hoffman La-Roche Ltd., Abbott Laboratories, Novartis AG, Alere, Inc., Siemens Healthcare, Bayer AG, Becton, Dickinson and Company etc. specializing in respective fields.
For the purpose of this study, the global molecular diagnostics market is categorized into the following regional and country specific markets:
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC
- Rest of Middle East and Africa
North America was observed as the largest market for molecular diagnostics in the base year 2016. The dominance of North America market is mainly attributed to rising number of infectious diseases requiring immediate diagnosis, increased government healthcare expenditure to promote public health and wellbeing and favorable reimbursement scenario. Europe is expected to be the second largest market due to high prevalence of cancer, technological advancement in diagnostic techniques and positive regulatory approval for molecular diagnostic products. Asia Pacific will be the fastest growing market for the forecast period 2017-2025, the factors that propel the market growth are large patient pool undergoing diagnosis for chronic diseases, infections and cancer, rise in market competition due to presence of existing and budding manufactures involved in production of molecular diagnostic solutions, and increasing disposable income in these regions. Factors such as development of large number of primary healthcare centers in remote areas, increasing disease awareness and increasing demand for molecular diagnostics are going to fuel the rapid growth of molecular diagnostic market in Latin America and Middle East and Africa region in the near future.
Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
Chapter 2. Executive Summary
2.1. Global Molecular Diagnostics Market Portraiture
2.1.1. Global Molecular Diagnostics Market, by Product, 2016
2.1.2. Global Molecular Diagnostics Market, by Technology, 2016
2.1.3. Global Molecular Diagnostics Market, by Application, 2016
2.1.4. Global Molecular Diagnostics Market, by Geography, 2016
Chapter 3. Molecular Diagnostics Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Prevalence Data of Major Target Diseases (Cholera, Malaria, Coronary Artery Disease, Diabetes, ESRD, & Chronic Kidney Diseases etc.)
3.3. Drivers
3.4. Challenges
3.5. Opportunities
3.6. Porter’s Five Forces Analysis
3.7. Attractive Investment Proposition, by Geography
3.8. Competitive Landscape
3.8.1. Competitive Landscape, by Key Players, 2016
Chapter 4. Global Molecular Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition: Global Molecular Diagnostics Market, by Product
4.3. Reagents and Kits
4.4. Instruments
4.5. Services and Software
Chapter 5. Global Molecular Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
5.1. Overview
5.1.1. Attractive Investment Proposition: Global Molecular Diagnostics Market, by Technology
5.2. Polymerase Chain Reaction
5.3. Isothermal Nucleic Acid Amplification Technology
5.4. Insitu Hybridization
5.5. Microarray
5.6. Others
Chapter 6. Global Molecular Diagnostics Market, by Application, 2015 – 2025 (US$ Mn)
6.1. Overview
6.1.1. Attractive Investment Proposition: Global Molecular Diagnostics Market, by Application
6.2. Infectious Disease
6.3. Oncology
6.4. Next Generation Sequencing
6.5. DNA Sequencing
6.6. Microbiology
6.7. Others
Chapter 7. Global Molecular Diagnostics Market, by Geography, 2015 – 2025 (US$ Mn)
7.1. Overview
7.2. North America Molecular Diagnostics Market Analysis, 2015 – 2025
7.2.1. North America Molecular Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
7.2.2. North America Molecular Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
7.2.3. North America Molecular Diagnostics Market, by Application, 2015 – 2025 (US$ Mn)
7.2.4. North America Molecular Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
7.2.4.1. U.S.
7.2.4.2. Canada
7.3. Europe Molecular Diagnostics Market Analysis, 2015 – 2025
7.3.1. Europe Molecular Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
7.3.2. Europe Molecular Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
7.3.3. Europe Molecular Diagnostics Market, by Application, 2015 – 2025 (US$ Mn)
7.3.4. Europe Molecular Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
7.3.4.1. U.K.
7.3.4.2. Germany
7.3.4.3. France
7.3.4.4. Rest of Europe
7.4. Asia Pacific Molecular Diagnostics Market Analysis, 2015 – 2025
7.4.1. Asia Pacific Molecular Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
7.4.2. Asia Pacific Molecular Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
7.4.3. Asia Pacific Molecular Diagnostics Market, by Application, 2015 – 2025 (US$ Mn)
7.4.4. Asia Pacific Molecular Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
7.4.4.1. Japan
7.4.4.2. China
7.4.4.3. India
7.4.4.4. Rest of APAC
7.5. Latin America Molecular Diagnostics Market Analysis, 2015 – 2025
7.5.1. Latin America Molecular Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
7.5.2. Latin America Molecular Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
7.5.3. Latin America Molecular Diagnostics Market, by Application, 2015 – 2025 (US$ Mn)
7.5.4. Latin America Molecular Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East & Africa (MEA) Molecular Diagnostics Market Analysis, 2015 – 2025
7.6.1. MEA Molecular Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
7.6.2. MEA Molecular Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
7.6.3. MEA Molecular Diagnostics Market, by Application, 2015 – 2025 (US$ Mn)
7.6.4. MEA Molecular Diagnostics Market, by Region, 2015 – 2025 (US$ Mn)
7.6.4.1. GCC
7.6.4.2. Rest of MEA
Chapter 8. Company Profiles
8.1. Abbott Laboratories, Inc.
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. Alere, Inc.
8.3. Bayer AG
8.4. Becton Dickinson and Company
8.5. BioMerieux SA
8.6. Bio-Rad Laboratories, Inc.
8.7. Danaher Corporation
8.8. F.Hoffman La-Roche Ltd.
8.9. Novartis AG
8.10. Qiagen N.V.
8.11. Siemens Healthcare
8.12. Sysmex Corporation
TABLE 1 Global Molecular Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 2 Global Molecular Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 3 Global Molecular Diagnostics Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 4 Global Molecular Diagnostics Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 5 North America Molecular Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 6 North America Molecular Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 7 North America Molecular Diagnostics Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 8 North America Molecular Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 9 Europe Molecular Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 10 Europe Molecular Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 11 Europe Molecular Diagnostics Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 12 Europe Molecular Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 13 Asia Pacific Molecular Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 14 Asia Pacific Molecular Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 15 Asia Pacific Molecular Diagnostics Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 16 Asia Pacific Molecular Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 17 Latin America Molecular Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 18 Latin America Molecular Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 19 Latin America Molecular Diagnostics Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 20 Latin America Molecular Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 21 Middle East and Africa Molecular Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 22 Middle East and Africa Molecular Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 23 Middle East and Africa Molecular Diagnostics Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 24 Middle East and Africa Molecular Diagnostics Market, by Region, 2015 – 2025 (US$ Mn)
TABLE 25 Abbott Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 Alere, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 Bayer AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 Becton Dickinson and Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 29 BioMerieux SA: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 30 Bio-Rad Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 31 Danaher Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 32 F.Hoffman La-Roche Ltd: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 33 Novartis AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 34 Qiagen N.V.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 35 Siemens Healthcare: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 36 Sysmex Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
FIG. 1 Molecular Diagnostics: Market Segmentation
FIG. 2 Global Molecular Diagnostics Market Share, by Product, 2016 (Value %)
FIG. 3 Global Molecular Diagnostics Market Share, by Technology, 2016 (Value %)
FIG. 4 Global Molecular Diagnostics Market, by Application, 2016 (US$ Mn)
FIG. 5 Global Molecular Diagnostics Market Share, by Geography, 2016 (Value %)
FIG. 6 Attractive Investment Proposition, by Geography
FIG. 7 Market Competition Landscape, by Key Players, 2016
FIG. 8 Global Reagents and Kits Market by Product, 2015 – 2025 (US$ Mn)
FIG. 9 Global Instruments Market by Product, 2015 – 2025 (US$ Mn)
FIG. 10 Global Services and Software Market by Product, 2015 – 2025 (US$ Mn)
FIG. 11 Global Polymerase Chain Reaction Market by Technology, 2015 – 2025 (US$ Mn)
FIG. 12 Global INAAT Market by Technology, 2015 – 2025 (US$ Mn)
FIG. 13 Global Insitu Hybridization Market by Technology, 2015 – 2025 (US$ Mn)
FIG. 14 Global Microarray Market by Technology, 2015 – 2025 (US$ Mn)
FIG. 15 Global Others Molecular Diagnostics Market by Technology, 2015 – 2025 (US$ Mn)
FIG. 16 Global Infectious Disease Market by Application , 2015 – 2025 (US$ Mn)
FIG. 17 Global Oncology Market by Application, 2015 – 2025 (US$ Mn)
FIG. 18 Global Next Generation Sequencing Market by Application, 2015 – 2025 (US$ Mn)
FIG. 19 Global DNA Sequencing Market by Application, 2015 – 2025 (US$ Mn)
FIG. 20 Global Microbiology Market by Application, 2015 – 2025 (US$ Mn)
FIG. 21 Global Others Molecular Diagnostics Market by Application, 2015 – 2025 (US$ Mn)
FIG. 22 U.S. Molecular Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 23 Canada Molecular Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 24 U.K. Molecular Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 25 Germany Molecular Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 26 France Molecular Diagnostics Market, 2015-2025 (US$ Mn)
FIG. 27 Rest of Europe Molecular Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 28 Japan Molecular Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 29 China Molecular Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 30 India Molecular Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 31 Rest of Asia Pacific Molecular Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 32 Brazil Molecular Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 33 Mexico Molecular Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 34 Rest of Latin America Molecular Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 35 GCC Molecular Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 36 Rest of Middle East and Africa Molecular Diagnostics Market, 2015 – 2025 (US$ Mn)
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)